Sweatman - Vertigo, Hearing Loss, N/V Flashcards

1
Q

What anti-histamines/anti-cholinergics are used to tx vertigo/N/V?

A
  • Meclizine hydrochloride
  • Diphenhydramine
  • Scopolamine
  • Promethazine HCl
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What benzo, CCS, and D2 antags are used to treat vertigo/N/V?

A
  • BENZO: Diazepam
  • CCS: Dexamethasone, Methylprednisolone
  • D2 ANTAGS: Prochlorperazine, Chlorpromazine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What 5-HT3 antags, NK1 antags, and cannabinoid receptor agonists are used to tx vertigo/N/V?

A
  • 5-HT3 ANTAGS: Dolasteron, Granisetron, Ondansetron, Palonosteron
  • NK1 ANTAGS: Aprepitant, Fosaprepitant
  • CANNABINOID AGONISTS: Dronabinol, THC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name 3 principle drugs that produce irreversible ototoxicity.

A
  • Aminoglycosides
  • Cisplatin
  • Loop diuretics (depending on circumstance of the individual pt)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is vertigo? Can drugs cause it? How?

A
  • Multisensory sensorimotor syndrome w/perceptual, postural, ocular motor, and autonomic manifestations induced by:
    1. Unusual, unadapted (motion) stimulation of intact sensory systems (motion sickness; height vertigo), or
    2. Pathological (lesional) dysfunction
  • Some 377 drugs/drug combos report vertigo as AE
    1. May be result of factors outside vestibular apparatus, like changes in BP leading to feeling of faintness
    2. Those with most prominent effects usually do so by impacting structure/func of vestibular apparatus (e.g., hair cells of inner ear)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 8 ototoxic/vestibulotoxic drugs? Which ones have a dose-dependent effect? Which are reversible?

A
  • Aminoglycoside and Cisplatin effects are IRREVERSIBLE
  • For loop diuretics, adverse consequence may be reversible, depending on circumstances of individual patient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do aminoglycosides cause ototoxicity?

A
  • Drug entry into outer hair cell leads to cell death by caspace-dependent or caspase-independent mechs
  • STEPS: AG entry into outer hair cell via mechano-electrical transducer channels
    1. Formation of AG-iron complex can react w/e- donors like AA to form ROS, like superoxide, hydroxyl radical, and hydrogen peroxide
    2. ROS can activate JNK, which can translocate to nucleus to activate genes in cell death pathway
    3. Genes can translocate to mito, causing release of cyt c, which can trigger apoptosis via caspases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does Cisplatin cause ototoxicity?

A
  • Entry into outer hair cells results in cell death due to primarily caspase-dependent mechanism
  • STEPS: CP entry into outer hair cell via mechano-transducer channels
    1. Can be aquated to form monohydrate complex (MHC) in cells, which is more highly reactive
    2. CP and/or MHC can activate NOX-3, resulting in ROS production -> ROS may activate JNK
    3. JNK can translocate to cell nucleus to activate genes involved in cell death pathway
    4. Genes translocate to mito, causing release of cyt c, which can trigger apoptosis via caspase-dependent mechanisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do the loop diuretics cause otoxicity?

A
  • Loops can cause either temporary or permanent loss of hearing by INH Na/K/2Cl co-transporter -> usually only temporary, but influenced by comorbid conditions
  • Animal studies: act on similar ion transport process in the stria vascularis (responsible for production and maintenance of endolymph), producing edema and temporary LOF (upset fluid balance), resulting in DEC in endocochlear potential
  • Effect dose-rate dependent -> conc gradient is critical factor in penetration of drugs into this part of body
  • This can result in secondary effects on sound-evoked measures of hearing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do you manage short-term tx of vertigo?

A
  • YELLOW X: H1 and M1 receptor antagonists
    1. Meclizine hydrochloride
    2. Diphenhydramine
    3. Scopolamine transdermal patch
    4. Promethazine hydrochloride
  • Diazepam (red x): useful for psychosomatic (anxiety-induced) vertigo, e.g., nausea arising from higher brain centers mediating fear, emotion, anticipation, etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the salient similarities b/t the muscarinic and histaminergic antagonists (table)?

A
  • Vary in duration of action: transdermal patch app of Scopolamine has longest (don’t touch, then touch eye)
  • All undergo hepatic metabolism
  • Diphenhydramine/Promethazine are CYP2D6 INH, so potential for drug-drug interactions
    1. BBW for severe tissue injury w/Promethazine injection (also, don’t use in under 2-y/o)
  • All capable of producing dizziness/drowsiness, and additive effects possible w/o/sedatives, anti-muscs
  • According to Beers criteria, all considered potentially inappropriate in geriatric pts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What should be in your DDx for N/V? Which causes should we focus on for the purposes of this lecture?

A
  • Agents in GI tract: alcohol, NSAID’s, oral AB’s
  • Drugs in circulation reaching chemo-trigger zone, where presence is sensed by specialized cells in direct contact w/passing blood: anti-tumor chemo, alcohol, CCB’s, opioids
  • Vestibular disorders via motion sickness/migraine: labyrinthitis, Meniere’s disease
  • Psychogenic factors via higher brain centers: anticipatory vomiting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is vomiting coordinated? Describe the pathways and chemicals involved.

A
  • Coordinated by central emesis center in lateral reticular formation of mid-brainstem, adjacent to (CTZ) chemoreceptor trigger zone in area postrema (AP) at bottom of 4th ventricle, and solitary tract nucleus (STN)
    1. Lack of BBB allows CTZ to monitor blood and CSF constantly for toxic substances and to relay info to emesis center to trigger N/V
  • Info also relayed from gut, mainly from Vagus (via STN), but also from splanchnic afferents via spinal cord
  • 2 other important inputs from cerebral cortex (esp. in anticipatory N/V) and vestibular apparatus (motion sickness)
  • Center then sends out efferents to nuclei responsible for resp, salivary, and vasomotor activity + striated smooth mm involved
  • NOTE: CTZ has high concentration of receptors for 5-HT3 (serotonin), D2 (dopamine), and opioids; STN rich in receptors for enkephalin, histamine, Ach, 5-HT3
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the role of vomiting? Steps?

A
  • Act of emesis/sensation of nausea generally viewed as protective reflexes that serve to rid stomach and sm intestine of toxic substances, preventing further ingestion
  • It is a complex process that consists of:
    1. Pre-ejection: gastric relaxation, retroperistalsis
    2. Retching: rhythmic axn of resp mm preceding vomiting, consisting of abdominal and intercostal mm and diaphragm against closed glottis
    3. Ejection: intense contraction of abdominal mm and relaxation of upper esophageal sphincter
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some features that accompany vomiting? What if it is protracted?

A
  • Accompanied by multiple autonomic phenomena, incl. salivation, shivering, and vasomotor changes
  • During protracted episodes, marked behavioral changes, incl. lethargy, depression, and withdrawal may occur
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What type of N/V are the 5HT-3 antagonists used for? MOA? Metabolism? AE’s?

A
  • Dolasteron, Granisetron, Ondansetron, Palonosteron: used clinically for moderate-severe N/V
  • MOA: act in CTZ and STN for CINV and PONV prophylaxis, often w/CCS
  • Hepatic metabolism: dose adjust in dysfunction only with Ondansetron
    1. Interaxns w/CYP INH, QT & PR/QRS prolongers
  • AE’s: hypersensitivity rxns (e.g., anaphylaxis), QT-prolongation (ECG monitoring recommended in select pts on Dolasetron or Ondansetron)
    1. Headache, constipation, diarrhea most comm side effects
17
Q

What are the MOA, metabolism, AE’s for the D2 antagonists (phenothiazines)? What are they used for?

A
  • Prochloperazine, Chlorpromazine: general purpose anti-nauseants and anti-emetics (NOT used for CINV)
    1. Also useful in motion sickness
  • MOA: D2 receptor antagonism at CTZ; also anti-chol, anti-histamine activity
  • Extensive hepatic metabolism, incl active metabolites
  • AE’s: chronic use -> bone marrow suppression/blood dyscrasias
    1. Assoc w/established risk of QT prolongation, torsades de pointe (drug interaxn possible)
    2. Co-admin w/antipsychotics/CNS depressants INC risk of CNS AE’s -> drowsiness, dizziness, orthostatic hypoTN, antichol effects, neuroleptic malignany syndrome (NMS), extrapyramidal symptoms (dyskinesia, dystonia), or seizures
    a. NMS: muscle rigidity, fever, autonomic instability, cognitive changes (delirium), and elevated plasma creatine phosphokinase
18
Q

What are the MOA, metabolism, and AE’s of the substance P/neurokinin-1 (NK-1) receptor antagonists?

A
  • Aprepitant, Fosaprepitant MOA: essential central action on solitary tract + peripheral effects (vagal terminals in GI tract)
  • Extensive hepatic (CYP) metabolism (3A4 INH): Fosa pro-drug activated by extra-hepatic metabolism
    1. Numerous potential interactions
  • AE’s: headache, constipation, diarrhea are common
19
Q

What are the use, MOA, metabolism, and AE’s of the cannabinoid receptor agonists?

A
  • Dronabinol, THC: G-protein coupled DEC neuronal activity in medullary vomiting center, STN -> oppose 5-HT3-mediated stimulation from vagal afferents
    1. Appetite stimulation via CB receptors in lateral hypothalamus: lower doses than for anti-emesis
  • Hepatic metabolism (CYPS?): active + inactive products
  • Schedule III drug: onset slow, gradual + only weakly reinforcing; many report dysphoric/unappealing effects
    1. Caution w/use in pts w/hx of substance abuse, incl alcoholism
  • AE’s: produces “high” -> easy laughing, emotional lability, elation, and heightened awareness
20
Q

Which anti-cancer drugs have the highest likelihood of producing emesis? Moderate likelihood?

A
  • HIGHEST (>90%):
    1. Cisplatin,
    2. Mechlorethamine,
    3. Streptozotocin,
    4. Cyclophosphamide >1500mg/m2,
    5. Carmustine,
    6. Dacarabazine
  • MODERATE (30-90%): Oxaliplatin, Cytarabine >1g/m2, Carboplatin, Ifosfamide, Cyclophosphamide <1500mg/m2, Anthracyclines (i.e., Doxorubicin), Irinotecan
21
Q

What is the prophylactic tx for anti-cancer drug-induced emesis? Unique element?

A
  • Serotonin receptor antagonist (-setron) + CCS, and possibly an NK-1 antagonist (Aprepitant) is tx of choice for prophylaxis against acute emesis
  • CCS (Dexamethasone, Methylprednisolone) are as effective as other drugs in prophylaxis of emesis, but rarely used alone (combos are rule)
    1. Presumably act on steroid receptors in STN; reduce release of serotonin has been proposed as alternative
22
Q

How important are CCS in controlling severe N/V?

A
  • VERY
  • Study showed that 22% of pts receiving anti-emetic monotherapy with Dolasetron required rescue meds vs. 6% of those treated w/2-drug combo (Dolasetron + Dexamethasone)